These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

994 related items for PubMed ID: 23810113

  • 1. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M, Date H, Wada H, Okubo K, Hamakawa H, Teramukai S, Matsumura A, Nakagawa T, Sumitomo S, Miyamoto Y, Okumura N, Takeo S, Kawakami K, Aoki M, Kosaka S, The Japan-Multinational Trial Organization.
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [Abstract] [Full Text] [Related]

  • 2. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T, Sawabata N, Funaki S, Inoue M, Kadota Y, Shintani Y, Okumura M.
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [Abstract] [Full Text] [Related]

  • 3. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S.
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [Abstract] [Full Text] [Related]

  • 4. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A, Salati M, Refai M, Xiumé F, Berardi R, Mazzanti P, Pompili C.
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [Abstract] [Full Text] [Related]

  • 5. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [Abstract] [Full Text] [Related]

  • 6. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G, Verderi E, Zuin A, Schiavon M, Battistella L, Perissinotto E, Romanello P, Favaretto AG, Pasello G, Rea F.
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [Abstract] [Full Text] [Related]

  • 7. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C, Yoon S, Lee DH, Park SI, Kim DK, Kim YH, Kim HR, Choi SH, Kim WS, Choi CM, Jang SJ, Song SY, Kim SS, Choi EK, Lee JC, Suh C, Lee JS, Kim SW.
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer.
    Kawasaki K, Sato Y, Suzuki Y, Saito H, Nomura Y, Yoshida Y.
    Ann Thorac Cardiovasc Surg; 2015 Nov; 21(3):217-22. PubMed ID: 25641029
    [Abstract] [Full Text] [Related]

  • 9. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B, Sequist L, Lee M, Muzikansky A, Heist R, Iafrate J, Dias-Santagata D, Mathisen D, Lanuti M.
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [Abstract] [Full Text] [Related]

  • 10. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF, Bohn BA, Uzunoglu FG, Reeh M, Quaas A, Grob TJ, Perez D, Kutup A, Bockhorn M, Izbicki JR, Vashist YK.
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [Abstract] [Full Text] [Related]

  • 11. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt.
    Meacci E, Cesario A, Cusumano G, Lococo F, D'Angelillo R, Dall'armi V, Margaritora S, Granone P.
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):656-63. PubMed ID: 21402479
    [Abstract] [Full Text] [Related]

  • 12. Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.
    Stefani A, Alifano M, Bobbio A, Grigoroiu M, Jouni R, Magdeleinat P, Regnard JF.
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):356-63. PubMed ID: 20381815
    [Abstract] [Full Text] [Related]

  • 13. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS.
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [Abstract] [Full Text] [Related]

  • 14. Should we operate on microscopic N2 non-small cell lung cancer?
    Fontaine E, McShane J, Carr M, Shackcloth M, Mediratta N, Page R, Poullis M.
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):956-61; discussion 961. PubMed ID: 21330443
    [Abstract] [Full Text] [Related]

  • 15. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW, Mortell KE, Talenfeld AD, Brunner MC.
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [Abstract] [Full Text] [Related]

  • 16. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
    Collaud S, Stahel R, Inci I, Hillinger S, Schneiter D, Kestenholz P, Weder W.
    Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
    [Abstract] [Full Text] [Related]

  • 17. Survival of patients with non-small cell lung cancer according to lymph node disease: single pN1 vs multiple pN1 vs single unsuspected pN2.
    Macia I, Ramos R, Moya J, Rivas F, Ureña A, Banque M, Escobar I, Rosado G, Rodriguez-Taboada P.
    Ann Surg Oncol; 2013 Jul; 20(7):2413-8. PubMed ID: 23378017
    [Abstract] [Full Text] [Related]

  • 18. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y, Sun BS, Zhang ZF, Zhang LM, Wang CL.
    Zhonghua Yi Xue Za Zhi; 2011 Jun 28; 91(24):1682-6. PubMed ID: 21914316
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
    Liu JW, Li J, Lin G, Shang XQ.
    Zhonghua Zhong Liu Za Zhi; 2013 Jan 28; 35(1):50-3. PubMed ID: 23648301
    [Abstract] [Full Text] [Related]

  • 20. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H, De Leyn P, Vansteenkiste J, Dooms C, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T.
    Eur J Cardiothorac Surg; 2009 Sep 28; 36(3):433-9. PubMed ID: 19502079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.